✦ Pharmaceutical manufacturers raised list prices for brand-name prescription drugs by a median of 5% in the first seven months of 2019, down from about 9% or 10% over those months in the prior four years. That’s according to an analysis of drug prices provided to the Associated Press by health information firm Elsevier. Several large manufacturers that are taking heat for high prices — including Pfizer Inc., Novartis International AG, Amgen Inc., AbbVie and Johnson & Johnson — skipped their usual mid-year increases, Elsevier drug pricing expert Kay Morgan told the AP. Nevertheless, there were 37 price hikes for every decrease in the first seven months of 2019.
- Datapoint, Medicare and Medicaid
- Abstract, Drug Benefits
- People on the Move
- Medicare and Medicaid
- Datapoint, Drug Benefits